| 9/29/2016 | BKCV | Moody’s: Alkermes loan Ba3
|
| 6/9/2011 | CV | S&P: Alkermes loans BB, B
|
| 5/22/2006 | BTCV | Alkermes to force conversion of 2.5% convertibles on June 15
|
| 2/17/2006 | CV | Market Commentary: Citadel gains on rumors of put-seeking hedge funds; Amgen's new issues continue week's climb
|
| 1/20/2006 | CV | Market Commentary: Hutchinson hovers around par; Schlumberger surges; Ford sags, Oscient tumbles
|
| 1/6/2006 | CV | Market Commentary: Convertibles market moves mostly in-line, dollar neutral; Best Buy, Cephalon gain; Affymetrix drops
|
| 8/23/2005 | CV | Market Commentary: Brocade convertibles move lower on call; Amylin gains outright but seen lower on a hedged basis
|
| 6/24/2005 | CV | Market Commentary: Convertibles mostly extend losses a second day; biotechs waver, but some energy issues see more gains
|
| 2/7/2005 | CV | Market Commentary: Southern Union, Protein Design launch; Pinnacle Airlines edges up, raises Northwest paper
|
| 2/3/2005 | CV | Market Commentary: Pinnacle Airlines ends at 101.625; Alkermes drops on earnings, deal; FEI up on earnings; Alamosa gains
|
| 12/31/2003 | CV | Alkermes says 98.4% of convertibles tendered, sells $60 million new notes
|
| 9/8/2003 | CV | Alkermes greenshoe exercised, raising convertibles to $125 million
|
| 8/19/2003 | CV | Market Commentary: InVision deal scrapped amid summer lull, officially citing adverse "market conditions"
|
| 8/19/2003 | CV | New Issue: Alkermes sells $100 million convertible to yield 2.5%, up 10%
|
| 8/18/2003 | CV | Alkermes $100 million overnighter talked to yield 2.0-2.5%, up 10-15%
|
| 8/18/2003 | CV | Market Commentary: Alkermes returns to convertibles market; InVision reslated deal sweetened once, then again
|
| 6/18/2003 | CV | Semtech calls 41/2% convertibles
|
| 1/8/2003 | CV | Market Commentary: Tyco dominates trading day, power issues surge on manipulation suit dismissal
|
| 1/7/2003 | CV | Market Commentary: Heavy trading on Tyco deal; InterMune dives, techs and telecoms soar, power mixed
|
| 1/7/2003 | CV | Market Commentary: Heavy trading on Tyco deal; InterMune dives, techs and telecoms soar, power mixed
|
| 12/20/2002 | CV | Comcast starts change-of-control tender on remaining $107.666 million convertibles due 2020
|
| 12/19/2002 | CV | Market Commentary: Market settles back into slow, holiday-like mode
|
| 12/17/2002 | CV | Deutsche: Alkermes exchange more appealing than Cell Therapeutics', but both likely to succeed
|
| 11/26/2002 | CV | Alkermes starts exchange for 3.75% convertibles
|
| 11/6/2002 | CV | Alkermes plans exchange offer for convertibles, to sell up to $50 million new securities
|
| 7/10/2002 | CV | Market Commentary: Stock plunge, earnings worries sideline players, pressure prices
|
| 7/1/2002 | CV | Market Commentary: Strong sell-off hits biotechs, drugs; Tyco pressure eases slightly
|
| 4/10/2002 | CV | JPMorgan recommends 9 biotech convertibles for yield, capital appreciation, relative value
|
